NCCR Urges Congress to Support Senate Bill for Cancer Research

August 1, 1996
Oncology NEWS International, Oncology NEWS International Vol 5 No 8, Volume 5, Issue 8

WASHINGTON--The National Coalition for Cancer Research (NCCR) has activated its 18 member organizations to write to Congress in support of S.1897, the NIH Revitalization Act of 1996. This legislation was introduced in the US Senate by Sen. Nancy Kassebaum (R-KS) to revise and extend certain programs of the NIH, including the National Cancer Institute (NCI).

WASHINGTON--The National Coalition for Cancer Research (NCCR)has activated its 18 member organizations to write to Congressin support of S.1897, the NIH Revitalization Act of 1996. Thislegislation was introduced in the US Senate by Sen. Nancy Kassebaum(R-KS) to revise and extend certain programs of the NIH, includingthe National Cancer Institute (NCI).

The legislation authorizes funding for the NCI at $3 billion andstrikes various cancer-specific earmarks, ie, allocations forbreast cancer, ovarian cancer, and prostate cancer. The NCCR supportsa balanced cancer research agenda and believes that earmarkingof site- and gender-specific research should not be supportedunless additional funds are provided for these priorities.